PHR

$11.86+0.09 (+0.76%)

Market ClosedAs of Mar 20, 8:00 PM UTC

Phreesia, Inc.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$11.86
Potential Upside
5%
Whystock Fair Value$12.45
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealth Information Services

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$715.00M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.72
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-1.68%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
2.44

Recent News

Zacks
Mar 20, 2026

Phreesia (PHR) Stock Jumps 5.1%: Will It Continue to Soar?

Phreesia (PHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Zacks
Mar 19, 2026

Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates

Nyxoah (NYXH) delivered earnings and revenue surprises of -4.62% and -2.46%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Mar 12, 2026

How The Phreesia (PHR) Story Is Shifting As Price Targets Fall And AI Tools Grow

Phreesia is back in focus as analysts trim price targets into the US$24 to US$26 range, while the modelled fair value in this update holds steady at US$28.05 per share. That gap reflects the current debate you are seeing in recent research, where firms are weighing execution on the path to profitability against questions about how much investors are willing to pay for growth in health tech. Read on to see what is driving this evolving narrative and how you can track it from here. Stay updated...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 12, 2026

CareCloud, Inc. (CCLD) Q4 Earnings Match Estimates

CareCloud (CCLD) delivered earnings and revenue surprises of 0.00% and +5.30%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Feb 20, 2026

Conestoga Capital Advisors Remains Confident in Phreesia (PHR) Amid Challenges

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. US equities experienced solid returns in 2025, with double-digit gains across all major indices. A copy of the letter can be downloaded here. In 2025, the Conestoga Micro Cap Composite met its purpose of preserving capital during negative market returns and capturing upside […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.